Excretory Profile of 4-Bromo-2,5-dimethoxy-phenethylamine (2C-B) in Rat
Tatsuyuki Kanamori, Kenji Tsujikawa, Yoshihito Ohmae, Yuko T Iwata, H. Inoue, Y. Inouye, T. Kishi
JOURNAL OF HEALTH SCIENCE April 1, 2003 DOI: 10.1248/jhs.49.166 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational study Peer reviewed |
|---|---|
| Population | Male Wistar rats |
| Intervention | 2C-B hydrochloride |
| Dose | 10 mg/kg |
| Duration | 0-24 and 24-48 hours after administration |
| Citations | 27 |
| Key findings | The major urinary metabolite of 2C-B in rats is 5-O-desmethyl-N-acetyl-2C-B, comprising 13.2% of the administered dose, with only 0.2% excreted unchanged. |
Abstract
The urinary and faecal metabolic profiles of 4bromo-2,5-dimethoxyphenethylamine (2C-B) in rat were investigated. Male Wistar rats were administrated 10 mg/kg of 2C-B hydrochloride orally, and the urine and faeces were collected 0‐24 and 24‐48 hr after administration. The samples were processed by liquidliquid extraction, and the extracts analyzed by GC/ MS, after derivatization. The major metabolite excreted into the urine was 5-O-desmethyl-N-acetyl-2CB, comprising 13.2% of the administrated dose. Other metabolites detected in the urinary extracts were 2-Odesmethyl-N-acetyl-2C-B (5.8%), 2-O-desmethyl-2CB (3.5%), carboxylic acid compound (1.9%), 5-Odesmethyl-2C-B (1.2%) and an alcoholic compound (0.8%). Only 0.2% of the administrated 2C-B was excreted into the urine in its original form. On the other hand, only 5-O-desmethyl-N-acetyl-2C-B and 2-Odesmethyl-N-acetyl-2C-B were detected in the faecal extracts. The major fraction of the urinary metabolites that contained a hydroxy group were recovered as conjugates.
Citations in the library
Cited by 5
- Metabolism of designer drugs of abuse: an updated review. Current Drug Metabolism June 1, 2010
- Identification of monoamine oxidase and cytochrome P450 isoenzymes involved in the deamination of phenethylamine-derived designer drugs (2C-series). Biochemical Pharmacology January 15, 2007
- Disposition of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) and its metabolite 4-bromo-2-hydroxy-5-methoxyphenethylamine in rats after subcutaneous administration. Toxicology Letters April 21, 2008
- Evaluation of commercial enzyme-linked immunosorbent assays to identify psychedelic phenethylamines. Journal of Analytical Toxicology September 1, 2011
- A study of the metabolism of methamphetamine and 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in isolated rat hepatocytes. Forensic Science International March 10, 2005